GlassScriptPhysician profile
Kathleen M Lowe
NPI 1639515315
$534.63
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $412 · 2020: $106 · 2021: $16.59.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $100.95 | 2019-2020 | |
| Novo Nordisk INC | $58.70 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $50.57 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.11 | 2019 | |
| Amarin Pharma, INC. | $48.37 | 2019 | |
| Amgen INC. | $41.39 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.51 | 2019 | |
| Sanofi-Aventis U.S. LLC | $30.16 | 2019 | |
| Abbott Laboratories | $24.86 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $23.51 | 2019 | |
| Genentech USA, INC. | $16.59 | 2021 | |
| Janssen Pharmaceuticals, INC | $16.19 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.94 | 2020 | |
| Lilly USA, LLC | $14.13 | 2019 | |
| Glaxosmithkline, LLC. | $11.65 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Lowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.